Hepatic Steatosis and its Effects on Fibrosis in Patients With Chronic Hepatitis B Virus Infection Mauricio Garcia-Saenz-de-Sicilia, MD, Andres Duarte-Rojo, MD, MS, DSC Clinical Gastroenterology and Hepatology Volume 16, Issue 4, Pages 491-494 (April 2018) DOI: 10.1016/j.cgh.2017.12.018 Copyright © 2018 AGA Institute Terms and Conditions
Figure 1 Point-of-care applicability of noninvasive assessment of fibrosis/steatosis monitoring. ChemoRx, chemotherapy; E2, estrogen; MTX, methotrexate. Clinical Gastroenterology and Hepatology 2018 16, 491-494DOI: (10.1016/j.cgh.2017.12.018) Copyright © 2018 AGA Institute Terms and Conditions